Objective: Identify barriers to timely intravenous (IV) tissue plasminogen activator (tPA) administration in the emergency department (ED) of one academic medical center in urban Philadelphia.Background: Early reperfusion therapy with thrombolysis via IV tPA and/or clot retrieval for patients with ...
Background Only 1-3% of ischemic stroke patients receive thrombolytic therapy. Provider barriers to adhering with guidelines recommending tPA delivery in acute stroke are not well known. The main objective of this study was to describe barriers to thrombolytic use in acute stroke care. Methods ...